We examined 6077 pediatric heart transplant donor-recipient (age ¡Ü 18 yrs) data entries from the Registry between 1987-2011. Recipients were stratified into 4 groups: donor male, recipient male (MM, n=1987); donor female, recipient male (FM, n=1447); donor female, recipient female (FF, n=1132); donor male, recipient female (MF, n=1511). The primary outcome endpoint was a composite of all-cause mortality or retransplantation.
MM patients had the best outcome overall (93 % at 30 days, 85.7 % at 1 year, 72.1 % at 5 years), and the MF group had the worst (90.5, 81.9 % , 66.8 % ). The MM group had a survival advantage compared to FM (91.0 % , 82.5 % , 69.6 % ), which became statistically significant after 5 years by log-rank test (p = 0.02), and approached significance (p=0.12) when adjusted for recipient age and primary diagnosis (cardiomyopathy, congenital heart disease or other) by Cox proportional hazard regression. The FF (91.3 % , 82.2 % , 70.1 % ) to MF comparison was not statistically significant. []
Male pediatric recipients have improved long term survival when they receive a sex-matched heart, consistent with the survival pattern seen in adult recipients. No survival advantage was seen for female recipients receiving a sex-matched heart.